Constellation Pharmaceuticals, Inc. has appointed Elizabeth G. Trehu to the Board’s Research and Development Committee and appointed Steven L. Hoerter to the Board’s Nominating and Corporate Governance Committee, in each case, effective January 7, 2019. Effective January 7, 2019, the R&D Committee will be constituted and its members will be Dr. Trehu, James Audia and Dr. Tepper. Dr. Audia will be the chairman of the R&D Committee. Mr. Hoerter will replace Robert Tepper on the Nominating and Corporate Governance Committee.